The Voice of Global Business in Japan Established in 1948 by representatives of 40 American firms, the ACCJ, a fully independent chamber of commerce, has grown into one of the most influential business organizations in Japan, with approximately 3,000 members representing over 40 countries and 600 companies. More than 60 Chamber committees, subcommittees, task forces, and advisory councils cover such diverse areas as financial services, corporate social responsibility, marketing, independent business, healthcare services, e-business, transportation and logistics, legal services, the travel industry, and human resource management. Each committee establishes goals at the beginning of the year and meets regularly to …

Type: NGO, Think-tanks, Ed, & Culture Activities: martech

Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and …

11 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating life science. Biocom California is the state’s most powerful life science advocate. We believe life science advances humanity and we support our member companies who share this vision with unparalleled resources to reach their full potential. Biocom California accelerates member success by driving effective public policy, creating access to capital, unlocking savings through robust member-vetted purchasing solutions, and developing the workforce of the future. We move the industry forward by building stronger networks across the state and building bridges from California to the rest of the world. Biotech, MedicalDevice, Diagnostic, Pharmaceuticals, ServiceProvider, Marketing, Networking and PurchasingGroup., Advocacy, Membership, Public …

Type: Incubators & VCs

A global health organization committed to saving lives, reducing the burden of disease and strengthening health systems. CHAI's mission is to save lives and improve health outcomes in low- and middle-income countries by enabling the government and private sector to strengthen and sustain quality health systems. Today, CHAI operates in 36 countries across the world and more than 80 countries have access to CHAI-negotiated price reductions, vaccines, medical devices, and diagnostics. Current programs at CHAI include HIV/AIDS, Malaria, Tuberculosis, Hepatitis, Maternal, Newborn and Reproductive Health, Diarrhea and Pneumonia, Nutrition, Vaccines, Health Financing, Health Workforce, and Cancer. CHAI also has a …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech

Increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Research for Tomorrow – Pioneering Drugs Against Infections. The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) was established in 2009 as a joint venture of the Helmholtz Centre for Infection Research (HZI) and Saarland University. Located on the Saarbrücken campus, we are Germany’s first research institute dedicated explicitly to pharmaceutical research, driving innovative solutions to combat infectious diseases. Our work focuses on the development of novel anti-infectives and their optimization for clinical application – with a clear translational approach. We integrate cutting-edge strategies in synthetic and natural product-based drug discovery with advanced methods in bioinformatics and drug delivery. Our mission: …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Reference information for the pharmaceutical sector Since 1992, economic, political and regulatory news from players in the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Report on major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Knowledge beckons. Since 1456 Short profile of the University of Greifswald The University of Greifswald is one of the oldest academic educational institutions in Germany and the Baltic Sea region. Founded in 1456, it is also the oldest Swedish university, as the region was under Swedish rule until 1815 after the end of the Thirty Years' War. Today it is a tradition-conscious and modern university on the Baltic Sea with diverse international relationships and partnerships. With around 220 professorships and around 10,000 students, it is one of the medium-sized universities. The low supervision ratio and the short distances enable intensive …

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

delivering therapies for inner ear disorders We are a clinical stage company delivering therapies for inner ear disorders hearing loss, pharmaceuticals, Meniere's Disease, and drug delivery

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Partner companies of your R&D The mission of AFSSI is to support and serve the development of human and animal health products. Founded in 2012, AFSSI represents service companies in preclinical R&D. With this unique sector in Europe, AFSSI responds to the global evolution of the pharmaceutical industry which entrusts the key stages of its R&D programs to expert companies like ours. The main field support for health innovation, AFSSI represents the leading R&D center in France, with 10,000 high-level jobs, 1 billion euros in turnover and 300 companies. Professional association, Sector development, Lobbying, Sector animation, Business, Service mapping, open …

Type: NGO, Think-tanks, Ed, & Culture Activities: consulting

Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria

40 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech deeptech

We provide advice on development strategies and events organisation to associations and learned societies Since its creation in 1953, Colloquium has been supporting numerous scientific societies and professional associations for the organization of their congresses or for the management of their associations: diabetes, ENT, orthodontics, gynecology, urology, chronic pain and radiology. In 2016 and to accompany the evolution of its client, Colloquium made a radical digital shift by restructuring 50% of its staff into web products development. 2017 will be a strategic step towards launching new products. Our services : - Digital communication agency - Professional Congress Organiser (PCO) - …

Type: Event

The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group. DeepTech industry analytics, benchmarking and forecasting renowned for its analytics and strategic consulting services on AI and DeepTech. Its Pharma Division is the leading provider of deep industry intelligence for the AI in Pharma sector. AI, artificial intelligence, big data, DeepTech, FinTech, data science, machine learning, GovTech, InvestTech, Blockchain, drug discovery, pharma, longevity, aging, healthspan, geroscience, agetech, preventive medicine, big data analysis, and data

98 similar entities Type: Startup Activities: it services Technologies: A.I. Data Analytics Blockchain/Cryptocurrency A.I. - Machine Learning

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify …

Type: Incubators & VCs NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech

Turning Research into Health The Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine. The BIH is dedicated to improving the prediction in progressive diseases and developing advanced therapies for unmet medical needs in order to improve patients’ health and quality of life. The Institute is committed to providing research solutions and innovation enabling value-based, personalized healthcare. The BIH is funded 90% by the Federal Ministry of Education and Research (BMBF) and 10% by the State of Berlin. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Since 1983, SOFILARO Gestion, a subsidiary of the Regional Banks of Crédit Agricole Languedoc and Sud Méditerranée, has played a dynamic role in the economic landscape of the region. Our mission? Support the development of local businesses as an active, long-term minority investor, consistent with the needs and economic pace of businesses. Our commitment is manifested through four investment funds: - SOFILARO provides equity support to mature companies in their development and transfers - CALEN (Crédit Agricole Languedoc Energies Nouvelles) invests in ENR infrastructures contributing to the region's energy transition - SOFILARO PRIVATE DEBT finances business growth through private bond …

Type: Incubators & VCs

Leading European Law Training Since 1992 - A Trusted Partner for Legal Professionals We are the leading organisation for continuous training in European law, offering valuable opportunities to learn, discuss, and network with high-level experts and legal practitioners from diverse professional backgrounds and countries. Attending ERA events not only deepens your understanding of the constantly evolving legal framework, but also positively impacts your legal career by enhancing your skills and expanding your professional network. Established in 1992 as a non-profit foundation, the Academy of European Law serves the European public interest by providing lawyers in private practice, in-house counsel, judges, …

Type: NGO, Think-tanks, Ed, & Culture Activities: legaltech

Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a SIX listed (BIOV) clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s two in house technology platforms: i) TRIC and ii)Ansamycin chemistry, BioVersys develops novel, innovative antibacterial drugs, overcoming resistance and modulating the microbiome. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our most advanced research and development programmes address nosocomial …

42 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The media network for Europe. Sign up for our free EU policy newsletters: https://www.euractiv.com/newsletters/ Euractiv publishes independent policy news and facilitates open policy debates in 12 languages. Our audience includes politicians, policymakers, business stakeholders, journalists, civil society, NGOs and other multipliers across Europe. We provide a platform where users can compare stakeholder positions, original source documents, videos and informed opinion. Learn more at: https://www.euractiv.com Opinions, Events, Videos, Infographics, Interviews, European Policymaking, Media, Journalism, Editorial, Languages, Policy Debates, EU News, European Union, and News

Type: Media

Our research leads to new strategies in the fight against infectious diseases. At the Helmholtz Centre for Infection Research (HZI), we investigate the mechanisms of infectious diseases and develop strategies to combat them. Our interdisciplinary teams work on innovative solutions, from basic research to clinical application, aiming to sustainably improve public health. Imprint: <https://www.helmholtz-hzi.de/en/imprint> Infection research, Wirkstoffforschung, Immunology, Antibiotika, One Health, Epidemiologie, Infektionsforschung, Antibiotics, Pathogens, infectious diseases, Infections, Diagnostics, Therapies, vaccines, Anti-infectives, Pharmaceutical research, RNA-based Infection Research, Experimentelle Infektionsforschung, Klinische Infektionsforschung, and Individualised Infection Medicine

Type: Public

Berlin can do health. Vivantes – with around 20,000 employees, Germany’s largest municipal hospital group and a strong healthcare network for Berlin and beyond. For 750,000 people per year, we provide excellent medical care and human touch around the clock. What makes us special? A dedicated team of Berliners and top international professionals who support each patient individually with competence and heart. Diversity, sustainability and innovation are a matter of course for us – in supply and in cooperation. We invest in good working conditions, development opportunities and real prospects, because we focus on people. Because: Working at Vivantes: Our …

Type: Large company

At Maze, we envision a world where genetic insights inspire new medicines. Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead …

12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss

34 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Focusing on Resistance in Antibiotic Development Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an …

12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders. Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders. sleep medicine and Obstructive Sleep Apnea

Type: Startup Activities: deeptech biotech

Integrated Drug Development from Discovery to Market - Part of the hVIVO plc Venn Life Sciences - part of hVIVO plc is an Integrated Drug Development partner offering an unique combination of drug development consultancy, clinical trial design and execution, enabling us to create, plan and execute drug development programmes effectively for our customers. Venn’s capabilities and expertise includes: CMC, Non-Clinical, Clinical Development and Regulatory Affairs. With our independent position we can design an optimal program including risk assessment and mitigation, saving time and money whilst achieving project milestone objectives. Visit our website - www.vennlifesciences.com for more information. Drug Substance …

5 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health …

Type: Large company

The trade association giving a bigger voice to small and mid-sized innovative health technology companies in Europe For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech

Reshaping drug discovery for patient benefit. Independent, not-for-profit national innovation centre for drug discovery. We collaborate with UK medicines discovery and diagnostics organisations, giving them access to expertise, technology, and high-quality data. We accelerate their progress, precision drugs get to clinical trials more rapidly, and patients get life-improving medicines earlier than they otherwise would have. biotechnology, pharma, medicines discovery, biotech, pharmaceuticals, drug discovery, tissue samples, discovery science and technology, virtual research and development, mass spectrometry, complex cell models, clinical data, biomarkers, tissue imaging, drug delivery, target engagement, target validation, omics, drug research, and Neuroscience

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech

ProductLife Group (PLG) is a global service provider in Life Sciences, delivering end-to-end consulting and outsourcing services across the entire product lifecycle. With a presence in 150+ countries, own resources in 50+ countries, and a team of over 2,000 professionals, PLG acts as a one-stop-shop partner for the pharmaceutical, biotechnology, medical device, nutrition, and cosmetics sectors. Our mission is to support clients in accelerating innovation, ensuring compliance, and ultimately improving human health. From Product Development to Market & Patient Access, from Regulatory Affairs and Safety & Vigilance to Consulting & Digital, our global experts join forces to shape the future …

Type: SMB Activities: biotech deeptech healthtech regtech Technologies: A.I.

Decoding cardiovascular disease biology for novel therapeutic discovery CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. The company leverages human multiomics data to better navigate complex disease biology to identify novel and differentiated therapeutics. CardiaTec is building the first and largest proprietary human heart tissue multiomics dataset. The company has a large and growing network of over 65 hospitals across the US and the UK, screening patients on a 24/7 basis to support the bespoke collection of human cardiac tissues. The company spun out of the Han Lab at the University of Cambridge …

50 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming promising life science ideas into medical breakthroughs that change patients’ lives. LifeArc® is a medical research charity making life science life changing, transforming promising life science ideas into medical breakthroughs that change patients’ lives. We are self-funding and specialise in early-stage translation – advancing lab-based scientific discoveries to a point at which they can be developed into the next generation of diagnostics, treatments and cures. We have been doing this for more than 25 years and our work has resulted in a diagnostic for antibiotic resistance and four licensed medicines. This includes Keytruda®(cancer), Actemra® (rheumatoid arthritis), Tysabri® (multiple sclerosis) …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech

Monthly peer-reviewed journal of public health. Fully open access and no author fees. Named authors alone are responsibl The Bulletin of the World Health Organization is a fully open-access journal of public health with a special focus on low and middle-income countries. It was first published in 1948 and, since then, has sought to make its full contents as widely available as possible. There are no article-processing charges associated with submitting to, or publishing in, the Bulletin. All peer-reviewed articles and the journal archives are indexed, including in the Web of Science and MEDLINE, and are freely available under the …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Advancing countermeasures against 21st century health threats. Part of HHS/ASPR. https://medicalcountermeasures.gov The ​​Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). BARDA enhances the nation's public health security and emergency preparedness by facilitating communication on innovative products and solutions between federal agencies and public stakeholders.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

The disease forecasting company, helping you track, predict, and simulate to achieve better disease outcomes. Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary …

Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Data Analytics A.I. - Machine Learning

Collaborating in the Fight for Health The Partnership to Fight Infectious Disease (PFID) is a group of patients, providers, community organizations, business and labor groups, and health policy experts working to advance awareness and action on antimicrobial resistance. As an initiative of the Partnership to Fight Chronic Disease, PFID is focusing on the impact of this growing issue on our population and health care system. In particular, we will explore and advance solutions to address the threat of antimicrobial resistance and the need for new antimicrobial treatments.

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 50 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, Our pharmaceutical solutions include active pharmaceutical ingredients (API), We are globally present across 40+ countries through alliances and partnerships with globally reputed majors. Our integrated business model enables us to cater to business opportunities throughout the value chain, from research to delivery of drugs across therapeutic …

Type: Large company

Non-profit global partnership funding the development of products that target the most serious drug-resistant bacteria CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germany’s Federal Ministry of Education …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. FRAXA Research Foundation is a national 501c3 nonprofit organization. FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. FRAXA also supports families affected by Fragile X syndrome and raises …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Our mission is to provide unwavering support for every family affected by Fragile X, while relentlessly pursuing a cure. The National Fragile X Foundation has been committed since the organization was formed in 1984 to help families, spread awareness, find improved treatments, and support research leading to better treatments and an eventual cure for all Fragile X-associated disorders. Mission The National Fragile X Foundation unites the Fragile X community to: - Enrich lives through educational and emotional support - Promote public and professional awareness - Advance research toward improved treatments and a cure for Fragile X. Advocacy, Support, Awareness, and …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

We’re the world’s leading business voice on aging-related policy and strategy. The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth.

Type: NGO, Think-tanks, Ed, & Culture Activities: consulting

Keeping Families Close since 1982. The Ronald McDonald House is located on the grounds of Jackson Memorial Hospital. At Ronald McDonald House, we provide essential services that remove barriers, strengthen families, and promote healing when children need healthcare. Human Services, Family, Children, Hospital services, Hospitality, Housing, Pediatric, Volunteers, Non profit, and Philanthropy

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Connecting Corporations & Communities Through CSR Teambuilding Events! Since 2005, Impact 4 Good has been helping companies make a difference through fun and meaningful CSR-focused teambuilding events. We know it’s not always easy to find activities that benefit your cause while also engaging employees—and that’s where we come in. Our mission is to bridge that gap by creating custom philanthropic teambuilding programs that connect companies with communities. Our events promote team bonding, strengthen connections across teams, and provide valuable donations to those in need. But, we do more than just teambuilding activities. We can help you find the right nonprofit …

Type: SMB Activities: cleantech

Pharmacists Advancing Healthcare ASHP is the largest association of pharmacy professionals in the United States, representing 60,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is the accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers. For more information, visit ashp.org and ASHP’s consumer website, SafeMedication.com. …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Furthering the advancement and impact of women in the business of healthcare. #HBAimpact The Healthcare Businesswomen’s Association (HBA) is a global professional association committed to furthering the advancement and impact of women in the business of healthcare. Mission The Healthcare Businesswomen’s Association is a global organization comprised of individuals and organizations in healthcare committed to: achieving gender parity in leadership positions facilitating career and business connections to accelerate advancement providing equitable practices that enable organizations to realize the full potential women HBA accomplishes its mission through strong business networks, education and leadership development, and global recognition for individuals and companies. …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

A global community working together to solve the challenges of infectious diseases. The Infectious Diseases Society of America is a global community of 13,000 clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks.

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

We help international companies set up successful business operations in Western Switzerland. Greater Geneva Bern area (GGBa) is the official investment promotion agency for Western Switzerland. Its mission is to support foreign companies so that they can quickly establish and develop their operations in Western Switzerland. Its services include: providing information on business environment, taxation, operational costs and labor law; facilitating contacts with peer companies and industry groups; evaluating the best location for each company’s needs and finding suitable premises. This support is provided at no charge and on a confidential basis. Since its creation in 2010, GGBa has successfully …

Type: Public Activities: fintech

Together, we’ll make life more inclusive for deaf people and those with hearing loss or tinnitus. Together, we’ll make life more inclusive for deaf people and those with hearing loss or tinnitus.

Type: SMB Activities: healthtech

Putting public health needs at the centre of antibiotic drug development to address the crisis of AMR The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech